Endothelial cells as key players in cerebral small vessel disease.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic pathways without original human data or systematic methodology
PubMed 39743557 · doi:10.1038/s41583-024-00892-0
What was done
This narrative review synthesized literature on the role of cerebral endothelial cell dysfunction in cerebral small vessel disease (SVD) pathogenesis, blood-brain barrier maintenance, neuro-glial-vascular unit interactions, and emerging drug therapies.
What was found
The abstract reports no quantitative metrics, effect sizes, or specific trial numbers. It reports that cerebral endothelial dysfunction alters blood vessel function, disrupts blood-brain barrier integrity, and impairs cell-cell communication in the neurovascular unit, driven by both extrinsic vascular risks and intrinsic genetic factors.
Why it matters
Standard vascular risk factor management has limited efficacy in preventing SVD progression; delineating endothelial mechanisms highlights potential molecular targets for targeted therapies.
Limits
The abstract contains no original human data, quantitative synthesis, or systematic search protocol. It presents qualitative narrative assertions without detailing specific trial sample sizes, drug classes, or clinical effect magnitudes.
Cited by
- supports Blood-brain barrier integrity and effectiveness decline with aging, diabetes, and cigarette smoking.